Sodium Citrate Blood Specimen Collection Tubes Market Size and Growth Opportunities and Forecast till 2026 - 2035
Sodium Citrate Blood Specimen Collection Tubes Market Size, Share & Trends Report, 2026–2035
LAST UPDATED: OCTOBER 2026
The global Sodium Citrate Blood Specimen Collection Tubes Market size was valued at USD 1.73 billion in 2025 and is projected to reach USD 3.24 billion by 2035, growing at a CAGR of 6.8% from 2026 to 2035. Growth is driven by rising coagulation testing for thrombosis, cardiovascular disease and anticoagulant monitoring, growing diagnostic test volumes, aging populations, expanding laboratory networks in Asia Pacific, and supply chain diversification after earlier tube shortages.
Sodium citrate blood specimen collection tubes, usually with a light blue cap, contain a buffered sodium citrate solution (commonly 3.2%) that binds calcium and stops blood from clotting. They are used to collect blood for coagulation tests such as prothrombin time (PT/INR), activated partial thromboplastin time (aPTT), fibrinogen and D-dimer. Accurate fill volume is critical because the blood-to-anticoagulant ratio affects test results.
Sodium Citrate Blood Specimen Collection Tubes Market Key Takeaways
Infographic: Sodium Citrate Blood Specimen Collection Tubes Market Size and Growth Opportunities and Forecast till 2026 - 2035 | Ameco Research
Sodium Citrate Blood Specimen Collection Tubes Market Report Scope
| Report Attribute | Details |
| Sodium Citrate Blood Specimen Collection Tubes Market Size in 2025 | USD 1.73 Billion |
| Sodium Citrate Blood Specimen Collection Tubes Market Forecast by 2035 | USD 3.24 Billion |
| Sodium Citrate Blood Specimen Collection Tubes Market CAGR (2026–2035) | 6.8% |
| Analysis Period | 2023–2035 |
| Base Year | 2025 |
| Forecast Period | 2026–2035 |
| Segments Covered | by End-User, and By Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | Becton, Dickinson and Company (BD), Greiner Bio-One International GmbH, Laboratory Corporation of America, AdvaCare Pharma, CML Biotech (P) Ltd., Neu Micromed International Pvt. Ltd., and FL MEDICAL s.r.l. |
| Report Coverage | Market Trends, Drivers, Restraints, Opportunities, Competitive Analysis, Player Profiling, Regulation Analysis |
Sodium Citrate Blood Specimen Collection Tubes Market Size Forecast, 2023–2035
The table below shows the year-by-year size of the global sodium citrate blood specimen collection tubes market. Revenue is expected to grow about 1.9 times between 2025 and 2035, reaching roughly USD 2.37 billion by 2030.
| Year | Market Size (USD Billion) |
| 2023 (historical) | 1.53 |
| 2024 (historical) | 1.62 |
| 2025 (base year) | 1.73 |
| 2026 (forecast) | 1.84 |
| 2027 (forecast) | 1.96 |
| 2028 (forecast) | 2.09 |
| 2029 (forecast) | 2.22 |
| 2030 (forecast) | 2.37 |
| 2031 (forecast) | 2.52 |
| 2032 (forecast) | 2.68 |
| 2033 (forecast) | 2.86 |
| 2034 (forecast) | 3.04 |
| 2035 (forecast) | 3.24 |
Latest Sodium Citrate Blood Specimen Collection Tubes Market Trends (2026)
Supply chain resilience
After the U.S. FDA added blood specimen collection tubes, including sodium citrate tubes, to its device shortage list in 2021, laboratories and health systems have diversified suppliers and kept higher safety stocks.
Shift to plastic tubes
Plastic (PET) evacuated tubes continue to replace glass because they reduce breakage and exposure risk and are easier to handle and dispose of, while maintaining vacuum and fill accuracy.
Laboratory automation
High-throughput labs use automated coagulation analyzers and tube handling systems, which favor standardized tubes with consistent fill volumes and barcode labeling.
Growing coagulation testing
Aging populations, cardiovascular disease, cancer-related thrombosis and wide use of anticoagulants are increasing PT/INR, aPTT and D-dimer test volumes.
Pre-analytical quality
Labs are focusing on correct tube order, fill volume and sample handling to reduce rejected samples, supporting training and tube designs with clear fill lines.
Expansion in emerging markets
New hospitals and diagnostic chains in India, China, Southeast Asia and the Middle East are increasing demand for blood collection consumables.
Sodium Citrate Blood Specimen Collection Tubes Market Dynamics
Growth drivers
- Rising cases of blood clots, such as deep vein thrombosis and pulmonary embolism
- Growing cardiovascular disease and anticoagulant use
- Increasing diagnostic and pre-surgical test volumes
- Expansion of hospitals and diagnostic chains in emerging markets
- Aging populations
Restraints and challenges
- Past supply shortages and dependence on a few large suppliers
- Price pressure in tender-based procurement
- Sample errors from incorrect fill volume or handling
- Regulatory requirements for medical device approval
Opportunities
Key opportunities include local manufacturing in Asia Pacific, Latin America and the Middle East, plastic and safety-engineered tubes, tubes for automated lab systems, and point-of-care and home coagulation monitoring support.
Sodium Citrate Blood Specimen Collection Tubes Market Segment Analysis
By end-user
The market is segmented into hospitals, diagnostic centers, medical clinics and others. Hospitals hold the majority share because they perform most coagulation tests for surgical, emergency and inpatient care. Diagnostic centers are growing quickly with the expansion of laboratory chains.
By material and format
Tubes are made in glass and plastic, in different draw volumes and citrate concentrations. Plastic evacuated tubes with 3.2% buffered sodium citrate are the most common format in modern laboratories.
Sodium Citrate Blood Specimen Collection Tubes Market Regional Analysis
Asia Pacific holds the leading share, supported by large patient populations, rising cardiac-related illnesses and blood clotting disorders, and expanding hospital and lab networks in India and China.
North America is a major market with high coagulation testing volumes, and has focused on supply resilience after the 2021 tube shortages. Europe is a mature market with established tube manufacturers.
Latin America and the Middle East & Africa are growing markets, supported by investments in hospitals and diagnostic labs.
Sodium Citrate Blood Specimen Collection Tubes Market Segmentation
Sodium Citrate Blood Specimen Collection Tubes Market Leading Companies
The sodium citrate blood specimen collection tubes market includes global blood collection device makers and regional manufacturers. Companies compete on fill accuracy, quality certification, supply reliability, price and compatibility with laboratory automation. Key players profiled in this report include Becton, Dickinson and Company (BD), Greiner Bio-One International GmbH, Laboratory Corporation of America, AdvaCare Pharma, CML Biotech (P) Ltd., Neu Micromed International Pvt. Ltd., and FL MEDICAL s.r.l..
Becton, Dickinson and Company (BD)Greiner Bio-One International GmbHLaboratory Corporation of AmericaAdvaCare PharmaCML Biotech (P) Ltd.Neu Micromed International Pvt. Ltd.FL MEDICAL s.r.l.
Key Questions Answered in This Report
- What is the size of the sodium citrate blood specimen collection tubes market in 2025, and how large will it be by 2030 and 2035?
- What are the main growth drivers, restraints and opportunities through 2035?
- Which by end-user segments will grow the fastest?
- Which regions and countries offer the largest and fastest-growing opportunities?
- How are supply resilience, plastic tubes and lab automation shaping demand for sodium citrate tubes in 2026?
- Who are the leading companies, and what strategies are they using to compete?
Research Methodology
Our estimates draw on interviews with blood collection tube makers, hospitals, diagnostic laboratories and distributors, supported by secondary data from annual reports, investor materials, trade and customs data, standards bodies and industry journals. Bottom-up estimates of company revenues and top-down estimates of application demand are reconciled through data triangulation, and the model is updated with 2026 developments to forecast the market through 2035.
Related Reports
- Blood Clot Retrieval Devices Market Analysis, Growth Opportunities, and Forecast 2026 - 2035 Report
- Blood Warmers Market Report
- Blood Filtering Device Market Report
- Ambulatory Blood Pressure Monitoring Devices Market Report
- Cosmetic Tubes Market Report
Sodium Citrate Blood Specimen Collection Tubes Market: Frequently Asked Questions
How big is the sodium citrate blood specimen collection tubes market?
The global sodium citrate blood specimen collection tubes market was valued at USD 1.73 billion in 2025 and is expected to reach USD 3.24 billion by 2035.
What is the growth rate of the sodium citrate blood specimen collection tubes market?
The sodium citrate blood specimen collection tubes market is projected to grow at a CAGR of 6.8% from 2026 to 2035.
What will the sodium citrate blood specimen collection tubes market be worth in 2030?
The sodium citrate blood specimen collection tubes market is projected to reach about USD 2.37 billion in 2030, growing at a CAGR of 6.8%.
What is driving growth in the sodium citrate blood specimen collection tubes market?
Key drivers are rising blood clot and cardiovascular cases, wider anticoagulant use, growing diagnostic test volumes and expanding lab networks in emerging markets.
What is sodium citrate blood specimen collection tubes?
Sodium citrate blood collection tubes are light blue-capped tubes containing sodium citrate that prevent clotting so blood can be used for coagulation tests such as PT/INR and aPTT.
Which region leads the sodium citrate blood specimen collection tubes market?
Asia Pacific holds the leading share, while North America and Europe are major markets.
Which segment holds the largest share of the sodium citrate blood specimen collection tubes market?
Hospitals are the leading end-user, accounting for the majority of coagulation testing.
What are the latest trends in the sodium citrate blood specimen collection tubes market?
The main 2026 trends are supply chain resilience, shift to plastic tubes, laboratory automation, growing coagulation testing, pre-analytical quality and expansion in emerging markets.
What are the main challenges in the sodium citrate blood specimen collection tubes market?
The main challenges are supply shortages, reliance on a few suppliers, price pressure, sample errors from incorrect fill volume and regulatory requirements.
Why is fill volume important in sodium citrate tubes?
Coagulation tests depend on a 9:1 ratio of blood to citrate solution, so under-filled tubes can give falsely prolonged clotting times and may be rejected.
Who are the key players in the sodium citrate blood specimen collection tubes market?
Leading companies include Becton, Dickinson and Company (BD), Greiner Bio-One International GmbH, Laboratory Corporation of America, AdvaCare Pharma, CML Biotech (P) Ltd., Neu Micromed International Pvt. Ltd., and FL MEDICAL s.r.l..
Related Healthcare Market Reports
- Mobile Surgical Unit Market Size and Growth Opportunities and Forecast till 2026 - 2035
- High Potent Active Pharmaceutical Ingredient (HPAPI) Market Size and Growth Opportunities and Forecast till 2026 - 2035
- Ambulatory Surgical Center Market Size and Growth Opportunities and Forecast till 2026 - 2035
- Gene Amplification Technologies Market Size and Growth Opportunities and Forecast till 2026 - 2035
- Healthcare Laboratory Information Market Size and Growth Opportunities and Forecast till 2026 - 2035